Extended-cycle oral contraception: a new option for routine use.

Anita L Nelson
{"title":"Extended-cycle oral contraception: a new option for routine use.","authors":"Anita L Nelson","doi":"10.2165/00024677-200504030-00002","DOIUrl":null,"url":null,"abstract":"<p><p>Extended use of oral contraceptive (OC) pills can successfully suppress endometrial activity and prevent menstruation for several months. Given that missed menses in women not using hormonal contraception may be of medical concern, understanding how hormonal contraceptives eliminate these concerns is important for both patient and healthcare provider acceptance. OC withdrawal bleeding is an artificial, iatrogenic event, which results from the deliberate, periodic interruption of hormonal support of the endometrium. Historically, it was important to provide periodic bleeding to reassure OC efficacy, but today it is recognized that these bleeding episodes are medically unnecessary and cause patient discomfort and out-of-pocket expenses. Decades of experience with prolonged use of OCs have been accumulated for women with specific menstrual-related problems such as endometriosis, dysmenorrhea, and menstrual migraine headaches. Today there is a US FDA-approved product to routinely reduce the number of withdrawal periods. Clinical trials show that there is an initial increase in unscheduled bleeding and spotting days with extended-cycle OC use, but an absolute decrease in total days of bleeding and spotting from the first cycle of use. Over time, unscheduled bleeding and spotting decreases to rates found with the use of conventional-cycle regimens. Every woman who is interested in using OC pills should be offered the opportunity to choose how to use them, to determine if and when she will have withdrawal bleeding.</p>","PeriodicalId":23310,"journal":{"name":"Treatments in Endocrinology","volume":"4 3","pages":"139-45"},"PeriodicalIF":0.0000,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2165/00024677-200504030-00002","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Treatments in Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2165/00024677-200504030-00002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Extended use of oral contraceptive (OC) pills can successfully suppress endometrial activity and prevent menstruation for several months. Given that missed menses in women not using hormonal contraception may be of medical concern, understanding how hormonal contraceptives eliminate these concerns is important for both patient and healthcare provider acceptance. OC withdrawal bleeding is an artificial, iatrogenic event, which results from the deliberate, periodic interruption of hormonal support of the endometrium. Historically, it was important to provide periodic bleeding to reassure OC efficacy, but today it is recognized that these bleeding episodes are medically unnecessary and cause patient discomfort and out-of-pocket expenses. Decades of experience with prolonged use of OCs have been accumulated for women with specific menstrual-related problems such as endometriosis, dysmenorrhea, and menstrual migraine headaches. Today there is a US FDA-approved product to routinely reduce the number of withdrawal periods. Clinical trials show that there is an initial increase in unscheduled bleeding and spotting days with extended-cycle OC use, but an absolute decrease in total days of bleeding and spotting from the first cycle of use. Over time, unscheduled bleeding and spotting decreases to rates found with the use of conventional-cycle regimens. Every woman who is interested in using OC pills should be offered the opportunity to choose how to use them, to determine if and when she will have withdrawal bleeding.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
延长周期口服避孕药:常规使用的新选择。
长期使用口服避孕药(OC)可以成功地抑制子宫内膜活动,并防止月经几个月。考虑到未使用激素避孕的女性错过月经可能是医学关注的问题,了解激素避孕药如何消除这些担忧对患者和医疗保健提供者的接受都很重要。子宫内膜撤除性出血是一种人为的医源性事件,它是由子宫内膜激素支持的故意、周期性中断引起的。从历史上看,定期出血以保证OC的疗效是很重要的,但今天人们认识到,这些出血发作在医学上是不必要的,会导致患者不适和自付费用。数十年来,对于患有子宫内膜异位症、痛经和经期偏头痛等特定月经相关问题的女性,长期使用口服避孕药的经验已经积累起来。今天,有一种美国fda批准的产品可以常规地减少停药期的数量。临床试验表明,延长用药周期后,最初出现的计划外出血和点滴天数增加,但从第一个用药周期开始,出血和点滴总天数绝对减少。随着时间的推移,意外出血和点滴出血的发生率降低到使用常规周期方案时的水平。每个对服用口服避孕药感兴趣的女性都应该有机会选择如何使用它们,以确定她是否以及何时会出现退断性出血。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Oxyntomodulin Prenatal treatment of congenital adrenal hyperplasia : do we have enough evidence? The role of melanocyte-stimulating hormone in insulin resistance and type 2 diabetes mellitus. The treatment of severe postmenopausal osteoporosis : a review of current and emerging therapeutic options. Thiazolidinediones : beyond glycemic control.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1